Top of PageSkip to main content

NSU-ARSH epidemiologist Jim Hall honored with award

Has worked in South Florida since the 1980s

Jim Hall, an epidemiologist with NSU’s Center for Applied Research on Substance Use and Health Disparities (NSU-ARSH) was recently honored for his work at the Florida Behavioral Health Conference.

Hall Hall

On Aug. 17, Hall received the Florida Alcohol & Drug Abuse Association (FADAA) Lifetime Achievement Award at the conference. ARSH is part of the College of Arts, Humanities, and Social Sciences’ Department of Justice and Human Services. Hall compiles local drug abuse data including hospitalizations, deaths, addiction treatment, prevalence, and drug pricing, strength and abuse trends, and works closely with local drug abuse coalitions, law enforcement, and other community organizations. He served as the executive director of Up Front Drug Information and Education Center in Miami from 1982-2012, and was the recipient of the 2010 Path of Public Health Award for Epidemiology and Disease Surveillance Services from Florida International University.

Hall was the first to report on the abuse of Rohypnol in 1992 and its use in multiple sexual assaults as the “date-rape drug.” He is credited with helping to ban Rohypnol from the United States. By the early 21st century, Hall led in the tracking of prescription drug abuse and Florida’s “pill mills.” His partnership with the United Way of Broward County’s Commission on Substance Abuse resulted in the establishment of Florida’s Prescription Drug Monitoring Program. He has continued to monitor changes in the emerging opioid epidemic throughout the new century. Hall became a major media source about the drug “Flakka,” and co-chaired the local Community Response Team which helped get that drug and 115 other synthetic substance banned by China in 2015.

Hall has provided testimonies before various US House and Senate Committees, as well as the Florida Legislature. He has represented the United States for the Department of State, NIDA, the European Drug Monitoring Centre, the United Nations, and the Organization of American States at numerous meetings worldwide. Hall serves on the Scientific Advisory Group of NIDA’s National Drug Early Warning System and the US Food and Drug Administration’s Drug Safety and Risk Management Advisory Committee.

Return to top of page